Since 2000, Novo Nordisk—a global healthcare company with more than 90 years of innovation and leadership in diabetes care—has been a valued JDRF partner. In that time, the company has contributed more than an amazing $13 million for type 1 diabetes (T1D) research through their global support of JDRF. Novo Nordisk shows its generosity in many ways—including sponsoring JDRF TypeOneNation Summits nationwide, the Bag of Hope for newly diagnosed children and Children’s Congress in support of our advocacy efforts. Their support of JDRF’s international affiliates extends to One Walk®, Gala and research activities. Novo Nordisk is also a valued member of the JDRF Industry Advisory Panel.
Novo Nordisk also helps advance JDRF’s mission by supporting:
- Local Chapter support through the Walk and Gala
- JDRF Ride to Cure Diabetes through a national corporate Ride team
- T1D Performance in Exercise and Knowledge (PEAK) program
We thank Novo Nordisk for all they do to help JDRF create a world without T1D.